We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
The Future of ADH1 - Looking at Emergent Treatments
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
CASR and ADH1: Integrating Biology and Genetic Screening
Therapeutic Options for ADH1 and Hypoparathyroidism
Emerging Therapeutics in ADH1: Progress in Precision Medicine
KOL KNOCKOUT™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease – Round 2
Malini Gupta, MD, ECNU, FACE
Kaniksha Desai, MD, ECNU, FACE
Rokshana R. Thanadar, MD, FACE, FEAA
Melissa Garduno Young, MD, FACE, FACP, ECNU
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Scott Kahan, MD, MPH
Ken Fujioka, MD
Carol Wysham, MD
Diagnostic Delay and the Critical Role of Personalized Screening Approaches in Cushing’s Syndrome
Maria Fleseriu, MD, FACE
Martin Reincke, MD
Recurrence of Cushing’s and the Changing Landscape of Medical Management
Richard Auchus, MD
Optimizing Outcomes of Cushing’s Disease Through Strategic Screening, Early Diagnosis, and Timely Treatment
Comprehensive Care and Medical Management of Acromegaly: Achieving an Earlier Diagnosis and Biochemical Control
Susan L Samson, MD, PhD, FRCPC, FACE
Eliza B. Geer, MD
Kevin C.J. Yuen, MD
Could Your Patient’s Symptoms Be Acromegaly?
Refining Screening and Referral in Frontline Care Settings
Making a Definitive Diagnosis
Guideline and Evidence-Based Best Practices for Treatment Sequencing
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education